Olaplex Shares Move Lower On Volume Following Short Report From The Bear Cave Titled ‘Problems at Olaplex Holdings (OLPX)’
https://thebearcave.substack.com/p/problems-at-olaplex-holdings-olpx
Worksport to Present SOLIS, COR Products For Three Global Automotive Manufacturers
Worksport Ltd. (NASDAQ:WKSP) (the "Company" or "Worksport"), is engaging in active negotiations with three major global automakers interested in partnering with the Company to develop unique
Chewy Launches CarePlus, Making Wellness and Insurance Plans Available to Millions of Pet Parents
Comprehensive wellness and insurance plans are empowering pet parents across the country to take a proactive approach to pet health
Chewy, Inc. ("Chewy") (NYSE:CHWY), a leading online destination for pet
StarHagen Joins the Velo3D Contract Manufacturer Network to Unlock Design Freedom for Aerospace Customers
Velo3D's End-to-end Solution Will Expand the Contract Manufacturer's Capabilities by Delivering High-quality Parts for High Performance Designs
Velo3D, Inc. ((VLD), a leading metal additive manufacturing
Physicians Realty Trust Q2 EPS $0.27 Up From $0.26 YoY, Sales $132.17M Beat $129.47M Estimate
Physicians Realty Trust (NYSE:DOC) reported quarterly earnings of $0.27 per share. This is a 3.85 percent increase over earnings of $0.26 per share from the same period last year. The company reported quarterly sales of
Atlas Air Worldwide Hldgs Q2 EPS $3.36 Beats $3.34 Estimate, Sales $1.18B Beat $1.11B Estimate
Atlas Air Worldwide Hldgs (NASDAQ:AAWW) reported quarterly earnings of $3.36 per share which beat the analyst consensus estimate of $3.34 by 0.6 percent. This is a 18.05 percent decrease over earnings of $4.10 per share
Spire Q3 EPS $0.01 Misses $0.02 Estimate, Sales $448.00M Beat $338.65M Estimate
Spire (NYSE:SR) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.02 by 50 percent. This is a 83.33 percent decrease over earnings of $0.06 per share from the same period
C4 Therapeutics Q2 EPS $(0.56) Down From $(0.51) YoY, Sales $13.83M Up From $9.78M YoY
C4 Therapeutics (NASDAQ:CCCC) reported quarterly losses of $(0.56) per share. This is a 9.8 percent decrease over losses of $(0.51) per share from the same period last year. The company reported $13.83 million in sales
Magenta Therapeutics Q2 EPS $(0.29) Up From $(0.32) YoY
Magenta Therapeutics (NASDAQ:MGTA) reported quarterly losses of $(0.29) per share. This is a 9.38 percent increase over losses of $(0.32) per share from the same period last year.